|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 278.00 TWD | +9.88% |
|
+11.65% | +45.17% |
| 02-26 | Test Research, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 01-08 | Test Research Logs NT$216 Million Profit in December | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 13.24 | 12.98 | 15.67 | 8.35 | 13.32 | |||||
Return on Total Capital | 16.06 | 16.37 | 19.99 | 10.38 | 16.32 | |||||
Return On Equity % | 19.71 | 20.09 | 28.76 | 13.86 | 23.75 | |||||
Return on Common Equity | 19.71 | 20.09 | 28.76 | 13.86 | 23.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 54.85 | 54.36 | 57.37 | 59.31 | 59.54 | |||||
SG&A Margin | 17.85 | 17.75 | 17.21 | 22.56 | 18.49 | |||||
EBITDA Margin % | 31.09 | 29.76 | 33.72 | 29.75 | 34.4 | |||||
EBITA Margin % | 29.28 | 28.05 | 32.33 | 27.62 | 32.23 | |||||
EBIT Margin % | 29.03 | 27.79 | 32.1 | 27.24 | 31.93 | |||||
Income From Continuing Operations Margin % | 22.07 | 21.14 | 28.64 | 22.58 | 28.9 | |||||
Net Income Margin % | 22.07 | 21.14 | 28.64 | 22.58 | 28.9 | |||||
Net Avail. For Common Margin % | 22.07 | 21.14 | 28.64 | 22.58 | 28.9 | |||||
Normalized Net Income Margin | 17.24 | 17.31 | 22.79 | 17.5 | 21.26 | |||||
Levered Free Cash Flow Margin | 17.98 | 4.5 | 6.57 | 17.76 | 3.61 | |||||
Unlevered Free Cash Flow Margin | 18 | 4.52 | 6.59 | 17.8 | 3.64 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.73 | 0.75 | 0.78 | 0.49 | 0.67 | |||||
Fixed Assets Turnover | 2.26 | 2.51 | 2.51 | 1.3 | 1.63 | |||||
Receivables Turnover (Average Receivables) | 2.55 | 2.61 | 2.49 | 1.66 | 2.33 | |||||
Inventory Turnover (Average Inventory) | 2.67 | 1.91 | 1.78 | 1.32 | 1.93 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.67 | 3.52 | 3.75 | 3.44 | 3.74 | |||||
Quick Ratio | 3.72 | 2.4 | 2.81 | 2.55 | 2.83 | |||||
Operating Cash Flow to Current Liabilities | 1.12 | 0.37 | 0.92 | 1.3 | 0.73 | |||||
Days Sales Outstanding (Average Receivables) | 143.39 | 139.63 | 146.83 | 219.45 | 156.96 | |||||
Days Outstanding Inventory (Average Inventory) | 136.97 | 191.26 | 204.98 | 275.82 | 189.91 | |||||
Average Days Payable Outstanding | 74.77 | 78.95 | 102.41 | 117.12 | 82.16 | |||||
Cash Conversion Cycle (Average Days) | 205.6 | 251.94 | 249.4 | 378.14 | 264.71 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.76 | 0.93 | 0.62 | 0.68 | 0.36 | |||||
Total Debt / Total Capital | 0.76 | 0.92 | 0.62 | 0.67 | 0.36 | |||||
LT Debt/Equity | 0.46 | 0.52 | 0.37 | 0.29 | 0.16 | |||||
Long-Term Debt / Total Capital | 0.46 | 0.51 | 0.36 | 0.29 | 0.16 | |||||
Total Liabilities / Total Assets | 18.51 | 23.89 | 20.78 | 19.32 | 18.36 | |||||
EBIT / Interest Expense | 1.05K | 1.01K | 922.66 | 439.88 | 716.86 | |||||
EBITDA / Interest Expense | 1.14K | 1.1K | 982.96 | 492.11 | 783.23 | |||||
(EBITDA - Capex) / Interest Expense | 1.12K | 1.01K | 696.95 | 180.46 | 652.15 | |||||
Total Debt / EBITDA | 0.03 | 0.03 | 0.02 | 0.04 | 0.01 | |||||
Net Debt / EBITDA | -1.12 | -0.81 | -0.61 | -0.96 | -0.58 | |||||
Total Debt / (EBITDA - Capex) | 0.03 | 0.04 | 0.03 | 0.1 | 0.02 | |||||
Net Debt / (EBITDA - Capex) | -1.14 | -0.88 | -0.85 | -2.63 | -0.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.85 | 13.25 | 19.66 | -33.89 | 43.31 | |||||
Gross Profit, 1 Yr. Growth % | 9.06 | 12.25 | 26.27 | -31.65 | 43.85 | |||||
EBITDA, 1 Yr. Growth % | 18.52 | 8.4 | 35.58 | -41.68 | 65.7 | |||||
EBITA, 1 Yr. Growth % | 20.11 | 8.5 | 37.89 | -43.52 | 67.24 | |||||
EBIT, 1 Yr. Growth % | 20.13 | 8.4 | 38.21 | -43.89 | 67.95 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 16.4 | 8.46 | 62.14 | -47.89 | 83.43 | |||||
Net Income, 1 Yr. Growth % | 16.4 | 8.46 | 62.14 | -47.89 | 83.43 | |||||
Normalized Net Income, 1 Yr. Growth % | 18.11 | 13.72 | 57.48 | -49.24 | 74.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 16.67 | 8.44 | 61.88 | -47.84 | 83.45 | |||||
Accounts Receivable, 1 Yr. Growth % | -2.07 | 23.5 | 27.72 | -23.84 | 36.45 | |||||
Inventory, 1 Yr. Growth % | 26.58 | 86.89 | -16.11 | -13.91 | 11.54 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.95 | 4.97 | 34.1 | 23.43 | 6.24 | |||||
Total Assets, 1 Yr. Growth % | 6.52 | 14.47 | 14.51 | -2.91 | 13.89 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.88 | 6.91 | 19.33 | -1.18 | 15.32 | |||||
Common Equity, 1 Yr. Growth % | 5.94 | 6.91 | 19.2 | -1.12 | 15.24 | |||||
Cash From Operations, 1 Yr. Growth % | -17.52 | -47.21 | 148.09 | 27.99 | -38.25 | |||||
Capital Expenditures, 1 Yr. Growth % | -10.43 | 286.94 | 381.96 | 28.25 | -56.65 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -22.34 | -71.64 | 74.59 | 78.73 | -70.86 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -22.33 | -71.56 | 74.5 | 78.52 | -70.7 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 36.36 | -26.67 | 51.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.32 | 13.05 | 16.41 | -11.06 | -2.67 | |||||
Gross Profit, 2 Yr. CAGR % | 1.62 | 10.65 | 19.06 | -7.1 | -0.84 | |||||
EBITDA, 2 Yr. CAGR % | 6.07 | 13.35 | 21.23 | -11.08 | -1.7 | |||||
EBITA, 2 Yr. CAGR % | 6.5 | 14.16 | 22.32 | -11.75 | -2.81 | |||||
EBIT, 2 Yr. CAGR % | 6.39 | 14.11 | 22.4 | -11.94 | -2.92 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.32 | 12.36 | 32.61 | -8.08 | -2.23 | |||||
Net Income, 2 Yr. CAGR % | 1.32 | 12.36 | 32.61 | -8.08 | -2.23 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.29 | 15.89 | 33.82 | -10.6 | -5.98 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.55 | 12.48 | 32.49 | -8.11 | -2.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5 | 9.98 | 25.59 | -1.38 | 1.94 | |||||
Inventory, 2 Yr. CAGR % | 1.2 | 53.81 | 25.21 | -15.02 | -2.01 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.38 | 1.97 | 18.65 | 28.66 | 14.51 | |||||
Total Assets, 2 Yr. CAGR % | 4.01 | 10.42 | 14.49 | 5.44 | 5.16 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.19 | 6.39 | 12.95 | 8.59 | 6.75 | |||||
Common Equity, 2 Yr. CAGR % | 3.25 | 6.42 | 12.89 | 8.57 | 6.75 | |||||
Cash From Operations, 2 Yr. CAGR % | 33.68 | -34.01 | 14.44 | 78.19 | -11.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.18 | 86.17 | 331.85 | 148.61 | -25.44 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 61.91 | -53.07 | -29.63 | 76.65 | -27.84 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 61.98 | -53 | -29.55 | 76.5 | -27.68 | |||||
Dividend Per Share, 2 Yr. CAGR % | -5.56 | 0 | 16.77 | 0 | 5.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.19 | 4.46 | 15.21 | -3.6 | 4.27 | |||||
Gross Profit, 3 Yr. CAGR % | 12.49 | 5.05 | 15.63 | -1.05 | 7.48 | |||||
EBITDA, 3 Yr. CAGR % | 21.71 | 6.84 | 20.32 | -5.01 | 9.42 | |||||
EBITA, 3 Yr. CAGR % | 23.78 | 7.16 | 21.58 | -5.46 | 9.21 | |||||
EBIT, 3 Yr. CAGR % | 23.79 | 7.06 | 21.64 | -5.62 | 9.21 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 22.47 | 3.64 | 26.97 | -2.87 | 15.73 | |||||
Net Income, 3 Yr. CAGR % | 22.47 | 3.64 | 26.97 | -2.87 | 15.73 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.97 | 5.27 | 28.37 | -3.13 | 11.66 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22.55 | 3.8 | 26.99 | -2.9 | 15.7 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.9 | 3.68 | 15.6 | 6.3 | 9.89 | |||||
Inventory, 3 Yr. CAGR % | 4.34 | 24.16 | 25.67 | 10.51 | -6.95 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.15 | 1.89 | 11.72 | 20.22 | 20.7 | |||||
Total Assets, 3 Yr. CAGR % | 4.9 | 7.39 | 11.77 | 8.37 | 8.19 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.32 | 4.41 | 10.54 | 8.03 | 10.79 | |||||
Common Equity, 3 Yr. CAGR % | 4.42 | 4.46 | 10.52 | 8.01 | 10.75 | |||||
Cash From Operations, 3 Yr. CAGR % | 65.2 | -1.92 | 2.61 | 18.79 | 25.16 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.97 | 59.27 | 155.63 | 188.12 | 38.89 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 90.17 | -9.41 | -27.28 | -3.99 | -3.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 90.23 | -9.29 | -27.22 | -3.95 | -3 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.23 | -3.74 | 10.89 | 0 | 14.86 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.81 | 12.58 | 13.25 | -2.05 | 7.7 | |||||
Gross Profit, 5 Yr. CAGR % | 1.39 | 12.45 | 15.07 | 0.01 | 8.73 | |||||
EBITDA, 5 Yr. CAGR % | 4.15 | 20.92 | 21.52 | -0.72 | 10.98 | |||||
EBITA, 5 Yr. CAGR % | 4.61 | 23.38 | 23.19 | -0.85 | 11.16 | |||||
EBIT, 5 Yr. CAGR % | 4.55 | 23.39 | 23.23 | -0.99 | 11.15 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 1.81 | 22.52 | 26.43 | -1.22 | 14.37 | |||||
Net Income, 5 Yr. CAGR % | 1.81 | 22.52 | 26.43 | -1.22 | 14.37 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.82 | 23.88 | 27.82 | -1.39 | 13.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 1.88 | 22.58 | 26.44 | -1.14 | 14.4 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.78 | 14.16 | 12.09 | 1.63 | 9.93 | |||||
Inventory, 5 Yr. CAGR % | 8.85 | 26.86 | 12.23 | 6.69 | 13.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.35 | 0.91 | 7.17 | 11.85 | 12.83 | |||||
Total Assets, 5 Yr. CAGR % | 1.03 | 6.77 | 8.64 | 6.6 | 9.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.01 | 3.46 | 7.69 | 6.07 | 9.01 | |||||
Common Equity, 5 Yr. CAGR % | 0.06 | 3.51 | 7.73 | 6.08 | 9 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.64 | 1.35 | 42.64 | 24.54 | -3.11 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.6 | 35.44 | 80.57 | 90.32 | 56.16 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.28 | -13.24 | 27.77 | 18.33 | -27.51 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.3 | -13.18 | 27.86 | 18.38 | -27.4 | |||||
Dividend Per Share, 5 Yr. CAGR % | -3.77 | 1.92 | 8.45 | -2.26 | 8.67 |
- Stock Market
- Equities
- 3030 Stock
- Financials Test Research, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















